Company Overview and News

9
Putnam stares down hedge funds on big shopping mall bet

2018-09-21 reuters
BOSTON (Reuters) - Putnam Investments has placed a large, concentrated bet that struggling U.S. shopping malls can transform themselves even as key tenants shut stores or file for bankruptcy.
SHLD PFH KTP JCP SHLDW SPG MORN

8
Stanley Black's CRAFTSMAN to Don New Logo, Offer New Products

2018-09-20 zacks
One of the most trusted brands of Stanley Black & Decker, Inc. (SWK - Free Report) , CRAFTSMAN, yesterday announced the adoption of a brand identity and launch of an array of products, tools and accessories. It’s worth noting here that CRAFTSMAN became part of Stanley Black in March 2017, when the Stanley Black acquired it from Sears Holdings Corporation . CRAFTSMAN strongly complements the company’s existing tools and storage brands.
SHLD SWK CFX SHLDW GTLS

7
Craftsman brand relaunches under Stanley Black & Decker with new tools

2018-09-19 marketwatch
The Craftsman brand has relaunched under new ownership, with Stanley Black & Decker Inc. SWK, +0.71% adding new tools to the lineup and introducing a new logo. Stanley Black & Decker bought the Craftsman brand from Sears Holdings Corp. SHLD, +0.00% in 2017 for about $900 million in cash. The new tool lineup includes a VersaStack portable storage system and a new range of tape measures, including pro-quality tape measures with up to 13 feet of standout.
SHLD SHLDW

22
Amazon's Big Step Into IoT

2018-09-18 seekingalpha
News recently broke that Amazon is looking to unveil 8 new IoT devices in the not-too-distant future.
SHLD GEC GE GNE SHLDW

7
Sears Holdings: Sales Improvement At The Cost Of Gross Margins

2018-09-15 seekingalpha
Sears reported -3.9% comps in Q2 2018 and positive comps for July and August, a marked improvement from previous periods.
SHLD SHLDW SCC SRSCQ SRSC

31
5 Top Stock Trades for Monday — Is GE Finally a Breakout Buy?

2018-09-14 investorplace - 1
A new round of tariffs sucked the wind out of the markets on Friday, but not enough to snowball any sort of large declines into the weekend. U.S. equities traded around flat on Friday, surprising given the decent rally we’ve had this week. Let’s look at our top stock trades.
SHLD GE GEC KR AAPL GNE SHLDW ETSY

7
Sears Holdings Corporation 2018 Q2 - Results - Earnings Call Slides

2018-09-14 seekingalpha
The following slide deck was published by Sears Holdings Corporation in conjunction with their 2018 Q2 earnings call.
SHLD SHLDW

9
Sears hints at revival while posting yet another quarterly loss

2018-09-14 theedgemarkets
(Sept 14): Investors shrugged off another quarterly loss by Sears Holdings Corp, sending the shares jumping as much as 20% in early trade, after the retailer said its performance stabilized this summer.
SHLD TGT SHLDW

7
Sears Shocks in Q2 Despite Massive Loss

2018-09-14 247wallst
Sears Holdings Corp. (NASDAQ: SHLD) reported its fiscal second-quarter financial results after the markets closed on Thursday. In a surprising reaction to these results, investors sent shares higher even though this retail chain is on its last legs.
SHLD SHLDW

18
Only Time Will Tell: CBL Is A 'Strong Sell'

2018-09-14 seekingalpha - 1
"Do not underestimate how much the lack of funds could hamper their redevelopment efforts.” Beyond Savings.
SHLD DDS JCP COST DKS SHLDW BBBY

9
6 Most Important Things In Business Today

2018-09-14 247wallst
Elon Musk’s SpaceX, demonstrating its founder and chief executive’s penchant for showmanship, announced that it had signed up the first private passenger seeking to fly around the moon. But the company provided no timetable or other details about the plan.
SHLD VLKAF FB SHLDW

8
Dead Meat Walking: Sears on Track to Zero Revenues & Zero Stores by 2020

2018-09-14 wolfstreet - 1
The headline said that shares of Sears Holding jumped “more than 7%” in late trading after it reported more losses and store closures and plunging revenues in its second quarter earnings report. By the time I checked it out, the stuff was up 22%, to a whopping $1.48, after having been down 9% during the day.
SHLD SHLDW

7
Sears' same-store sales losses narrow but warns it may go out of business

2018-09-14 channelnewsasia
Sears Holdings Corp reported a smaller decline in quarterly same-store sales on Thursday, but warned again that there is doubt about the company's continued operation as it awaits approval to sell some of its businesses to its chief executive's hedge fund.
SHLD SHLDW

7
Sears' same-store sales losses narrow but warns it may go out of business

2018-09-14 reuters
(Reuters) - Sears Holdings Corp (SHLD.O) reported a smaller decline in quarterly same-store sales on Thursday, but warned again that there is doubt about the company’s continued operation as it awaits approval to sell some of its businesses to its chief executive’s hedge fund.
SHLD SHLDW

7
Sears Q2: It's Only Getting Worse

2018-09-13 seekingalpha
One of my best short ideas this year so far has been struggling retailer Sears Holdings (SHLD). As the company continues to close stores and try to get its perilous financial situation in check, shares have plunged to new lows. Unfortunately while shares have surged thanks to the latest quarterly report, it didn't do too much to ease fears that the worst may be yet to come.
SHLD SHLDW

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...